Microsoft partners with Cruise to commercialize self-driving vehicles

Microsoft Corp. is joining hands with Cruise, the self-driving subsidiary of General Motors., to help accelerate the commercialization of driverless autonomous vehicles. The Redmond-based company will offer Azure, Microsoft’s cloud computing platform, for Cruise’s self-driving vehicles. For its part, Microsoft will use Cruise’s technology and expertise to expand into the transportation sector.

“Advances in digital technology are redefining every aspect of our work and life, including how we move people and goods,” said Microsoft CEO Satya Nadella said in a statement. “As Cruise and GM’s preferred cloud, we will apply the power of Azure to help them scale and make autonomous transportation mainstream.”

Cruise Car

Cruise car in San Francisco streets. (Image Credit: Cruise Origin)

Microsoft and Cruise are entering a “long-term strategic relationship” – although this partnership will not be exclusive.

Today’s announcement is a milestone for Microsoft considering it’s the software giant’s first partnership with a self-driving car company.

General Motors will work closely with Microsoft to help speed up the automaker’s digitization initiatives, including machine learning and artificial intelligence and explore opportunities to streamline its operations across supply chains in order to bring its services to customers faster.

Cruise is one of the few self-driving car companies to receive funding from tech bigwigs and top venture capitalists. Even though it hasn’t made as much progress as rival Waymo in terms of achievements.

In 2018, Cruise received a $2.25 billion investment from the SoftBank Vision Fund. In the same year, General Motors teamed up with Honda Motors to develop a self-driving car. The Japanese carmaker announced it would invest $2 billion over a period of 12 years to venture into the autonomous vehicles business. It also announced a $750 million equity investment in Cruise.

In 2019, Cruise secured a $1.15 billion investment from General Motors, Honda, SoftBank, and T. Rowe Price Group. The most recent round of investments brought its valuation to $19 billion.

Cruise is currently testing its fully autonomous driverless vehicles in San Francisco. The company planned to launch a commercial taxi service in 2019 but missed the goal, and is yet to commit to a new date.

Subscribe to the nation’s fastest-growing business magazine to get the latest business news delivered to your inbox. 

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

UK watchdog whacks Amazon with probe for unfair data collection practices

UK watchdog whacks Amazon with probe for unfair data collection practices

The Competition and Markets Authority will focus on whether Amazon, Inc. favors merchants that use its delivery services.
2 days ago
Altice buys 12 percent stake in BT worth £2 billion

Altice buys 12 percent stake in BT worth £2 billion

Altice said it did not intend to make a bid for the British Telecoms company, though the takeover code also does not allow it to make an unsolicited buyout offer for six months wit
2 days ago
G7 countries agree on broad principles of minimum corporate tax deal

G7 countries agree on broad principles of minimum corporate tax deal

The world’s richest nations (G7) reached a landmark accord setting a global minimum corporate tax rate for multinationals. Would it be effective in tackling tax evasion and avoid
2 days ago
BC Partner goes the Continuation Fund way to strike a $7bn deal

BC Partner goes the Continuation Fund way to strike a $7bn deal

BC Partners, a UK private equity firm, has floated a “continuation fund” deal, one of Europe’s largest such deals, by transferring its 47 per cent stake in the academic publi
3 days ago
FDA approves Biogen’s $56,000 drug for Alzheimer’s

FDA approves Biogen’s $56,000 drug for Alzheimer’s

The Food and Drug Administration of the US approved on Monday Biogen Inc’s Aducanumab to treat Alzheimer’s disease amidst the controversy of its efficacy. Biogen has pr
4 days ago
UK watchdog’s plans for big banks to draw fair compete rules draws criticism

UK watchdog’s plans for big banks to draw fair compete rules draws criticism

Under UK Finance’s proposals, nine banks under investigation by the CMA would be obliged to fund a “future entity” for three years.
4 days ago